“We view the liquidity boost as positive for the stock market,” say CGSI analysts Lock Mun Yee and Lim Siew Khee. “In addition to liquidity, fundamental and investible theses remain the key focus for investors, and we see broadening of research and improving listing support, investor protection and confidence as complementary to the entire value chain.”
Yangzijiang is a laggard in the industrials space and its valuation remains cheap relative to the MSCI Singapore Index, the analysts say.
They also include SGX on potential virtuous cycle impact from the EQDP, HLA on re-rating of the construction sector and LHN on the potential monetisation of its co-living business.
In addition to the companies mentioned, CGSI also picks Keppel, SATS, and UOL Group among large-caps and CSE Global, Food Empire Holdings, Marco Polo Marine and Q&M Dental Group among small-cap stocks.
See also: JP Morgan upgrades Suntec REIT to 'overweight' on better occupancy, lower interest cost
Table: CGSI
Strengthening investor protection
See also: What does Singapore at 60 mean for the REIT sector?
MAS has appointed Avanda Investment Management, Fullerton Fund Management and JP Morgan Asset Management as the first batch of asset managers that will launch fund strategies under the EQDP, announced the central bank and financial regulator on July 21.
MAS will place a combined initial sum of $1.1 billion with the three firms, out of $5 billion that has been set aside for the EQDP.
MAS is reviewing the submissions in batches to speed up the appointment and deployment process. By 4Q2025, MAS expects to announce the second batch of asset managers that will manage the remaining funds under the EQDP.
MAS has also announced a $50 million commitment to enhance the Grant for Equity Market Singapore (GEMS) scheme, which has been extended from end-2026 to end-2028. The additional sum has been set aside from the Financial Sector Development Fund (FSDF).
The enhanced Research Development Grant will provide additional funding of $1,000 for each research report, with a further $1,000 for initiation reports and research on pre-initial public offering (IPO) firms and newly-listed companies.
The raised amount takes the maximum funding from $4,000 currently to $6,000 per research report, and takes effect from July 21.
According to MAS, the enhanced funding aims to “boost investor awareness” and trading interest within “under-researched” segments, particularly in small- and mid-cap companies.
For more stories about where money flows, click here for Capital Section
Read also:
- MAS picks Avanda, Fullerton, JP Morgan under $5 bil Equity Market Development Programme
- MAS to consult on ways to enhance investor recourse
- S’pore stocks are ‘longer-term investments’, not just for ‘short-term punting’: Chee Hong Tat
- Maybank Securities picks 18 non-STI stocks that stand to win from MAS’s market reforms
- DBS picks seven ‘stocks to watch’ from Avanda’s coming fund strategy
- These are the 10 stocks that could be the ‘biggest winners’ of MAS’s $1.1 bil distribution, says UOBKH
Read more about the equities market review group:
- Review group's measures can help 'break the inertia' of IPOs vs liquidity, says Clifford Lee of DBS (Feb 23)
- Equities market review group targeting ‘mid-sized but good-sized’ companies to list in Singapore (Feb 23)
- New family offices may contribute $15 billion to local bourse this year, suggests Maybank's Wickramasinghe (Feb 23)
- Proposing equity market changes a ‘balancing act’ that comes with ‘trade-offs’: Chee Hong Tat (Feb 22)
- 'This has definitely made my Friday': Azure's Wong (Feb 22)
- Plenty of overseas liquidity to be tapped amid plan to nudge family office money into local equities: Lang (Feb 21)
- ‘Unaddressed elephant in the room’: Reservations about MAS equities market review group’s proposals (Feb 17)
- SGX shares close 5.8% lower after MAS equities market review group’s first proposal (Feb 14)
- MAS’s equities market review group proposes tax incentives as part of measures to boost Singapore’s bourse (Feb 13)
- Revitalising SGX: Beyond liquidity injections (Feb 6)
- ‘Not practical’ to rely on sovereign wealth to support, sustain Singapore equities: Gan Kim Yong (Jan 2)
- SGX Group chairman calls for ‘bold and decisive actions’ to solve stock market’s ‘longstanding issues’ (Jan 2)
- Making the Singapore market great again (October 2024)
- Revitalising Singapore equities market ‘not an easy task’, says Chee Hong Tat (September 2024)
- MAS’s equities market review group holds first meeting, unveils 31 workstream members (August 2024)
- MAS launches review group to strengthen equities market; recommendations to come within a year (August 2024)